provider_review · verified 2026-09-02
Goldspan Health review
"$199 /month" in the hero, "Billed every 28 days" on the plan card of the same page
Twenty-eight-day billing is thirteen charges a year, not twelve. Goldspan publishes no annual figure and no per-month equivalent to resolve the two.
How this site makes money
Plain version: a handful of the outbound links here are affiliate or referral links. Follow one, start a treatment or buy a product, and we may earn a commission — your price stays exactly the same. That money pays for the research, and what we write about any product — and the price you pay — are the same either way. Want the specifics? Read the full disclosure.
at_a_glance
- price
- "From $199 /month" in the hero and $199.00/month on the catalog card.
- what you pay
- No monthly rate can be filed. The plan card says "Billed every 28 days", which is thirteen charges a year rather than twelve.
- pharmacy
- No pharmacy is named. 503A and 503B are stated as a class on the NAD+ page, with no facility identified.
- states
- The storefront footer, printed on the NAD+ page itself, says available in all 50 states and Washington D.C.
- on our index
- Ranked #42 of 48 on our NAD+ provider index.
verdict
The short version
Goldspan offers exactly one NAD+ plan, so its "From $199" floor and its standing rate are the same figure today — no ladder to misread. What it does have is a cycle problem. The hero says "From $199 /month", the catalog card says $199.00/month and the payload calls the cadence monthly, while the plan card on the same page says "Billed every 28 days". Those are not the same thing: thirteen charges across a year is $2,587 rather than $2,388. The site publishes no annual total and no per-month equivalent, so the difference is left entirely to the reader. 503A and 503B are stated as a class, with no facility named. We are not paid by Goldspan.
evidence
What the evidence for this route shows
The route sold here is a subcutaneous injection. No published randomized human trial shows meaningful energy or focus benefit from injected NAD+; the human evidence that exists sits with the oral NR precursor. See our evidence review.
pricing
What it actually costs
- advertised
- "From $199 /month" in the hero and $199.00/month on the catalog card.
- you pay
- No monthly rate can be filed. The plan card says "Billed every 28 days", which is thirteen charges a year rather than twelve.
- the catch
- The page states its cadence two ways. Thirteen 28-day charges come to $2,587 across a year against the $2,388 a monthly reading implies, and no annual figure is published to settle it.
Other money you will meet
- Only one plan exists, so there is no prepay ladder behind the floor
source :: read at altroapp.com on 2026-09-02, in a browser that runs JavaScript.
fit
Who this is and is not for
Buy it if
- You want one plan and no prepay ladder to decode
- You want the 28-day cycle disclosed somewhere rather than hidden entirely
- You want coverage stated as all 50 states and Washington D.C. on the NAD+ page itself
Look elsewhere if
- You budget monthly — this bills thirteen times a year, not twelve
- You want an annual figure; none is published
- You want the compounding pharmacy named
included
What is inside the price
- consult
- Included, described as evaluation and prescription.
- labs
- Not included, and not required.
- follow-ups
- Included, described as messaging the clinical team.
- human support
- Included, described as messaging the clinical team. No hours published.
- supplies
- Not itemized.
- shipping
- Included, though the word "free" is not used.
the_knock
What they would rather you skipped
A page that says "/month" three times and "Billed every 28 days" once is not disclosing a cycle, it is burying one. Thirteen charges a year against twelve is $199 more than a reader budgeting monthly will expect, and Goldspan publishes no annual total and no per-month equivalent anywhere to close the gap.
And the rest
- "/month" and "Billed every 28 days" appear on the same page — the real cadence is thirteen charges a year
- No annual figure or per-month equivalent is published to resolve the contradiction
- 503A and 503B are stated as a class with no pharmacy named
- We earn nothing on it — there is no affiliate relationship here
tools
Work out your own number
Every figure on this page was read on Goldspan Health’s own site on 2026-09-02 in a browser that runs JavaScript, and prices change without notice. Compare it against the rest of the field on our NAD+ provider index, or read every provider review.
Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.